Cellect (APOP) Reports First Successful Stem Cell Transplant Procedure Using its ApoGraft Technology – StreetInsider.com
|
Cellect (APOP) Reports First Successful Stem Cell Transplant Procedure Using its ApoGraft Technology
StreetInsider.com Cellect Biotechnology Ltd. (Nasdaq: APOP) announced today that the first stem cell transplant procedure has been successfully performed using its ApoGraft™ technology in the Company’s Phase I/II clinical trial in a blood cancer patient. Up to 50 … |
|
Cellect (APOP) Reports First Successful Stem Cell Transplant Procedure Using its ApoGraft Technology
StreetInsider.com Cellect Biotechnology Ltd. (Nasdaq: APOP) announced today that the first stem cell transplant procedure has been successfully performed using its ApoGraft™ technology in the Company’s Phase I/II clinical trial in a blood cancer patient. Up to 50 … |
New Atlas |
“Immortalized” stem cells produce bigger, better blood batches
New Atlas Donating blood saves lives, but there’s never enough, especially when the difficulties of storage and matching blood types are taken into account. Artificial blood has been in the works for years, but it’s held back by the fact that the stem cells it’s … Stem Cells Show Mixed Results for Impotence After Prostate SurgeryNBCNews.com Stem cell breakthrough offers hope for men with erectile dysfunction after prostate surgeryThe Independent Stem cells help some men with erectile dysfunction after prostate surgeryThe Guardian News18 –Jamaica Observer –Medical News Today –University of Bristol all 60 news articles » |
|
EAU 2017: State-of-the-art Lecture: How will Immunotherapy Change the Treatment Paradigm?
UroToday Dr. Jones concluded this thought provoking session by noting that immunotherapy is here to stay as second line treatment and we urgently need to understand patient selection in the first line setting. Ultimately, we need careful research to “harness … |